On the last page in the section "About Syntara" it says that SNT-4728 is being "studied" in collaboration with Parkinson's UK. Although the word "studied" is deployed I had understood that a clinical trial in this indication is underway. Is this correct?
It also says regarding SNT-5505 that protocols for another two phase 1c/2 studies with SNT-5505 in patients with a blood cancer called myelodysplastic syndrome are in development and expected to commence recruitment by H1 2025. This suggests that two new clinical trials using SNT-5505 will commence this half year. Is this new news? Is this interpretation correct?
- Forums
- ASX - By Stock
- SNT
- Ann: Quarterly Shareholder Report
SNT
syntara limited
Add to My Watchlist
0.00%
!
5.7¢

Ann: Quarterly Shareholder Report, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.76M |
Open | High | Low | Value | Volume |
5.7¢ | 5.8¢ | 5.6¢ | $57.98K | 1.029M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 493270 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 102824 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 493270 | 0.056 |
4 | 1335347 | 0.055 |
2 | 324000 | 0.054 |
1 | 100000 | 0.051 |
3 | 630000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 102824 | 1 |
0.058 | 157493 | 1 |
0.059 | 200000 | 1 |
0.060 | 57800 | 2 |
0.061 | 87966 | 1 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |